Literature DB >> 21349440

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.

Thomas Philips1, Wim Robberecht.   

Abstract

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) are characterised by the appearance of reactive microglial and astroglial cells, a process referred to as neuroinflammation. In transgenic mouse models of mutant SOD1-associated familial ALS, reactive microglial cells and astrocytes actively contribute to the death of motor neurons. The biological processes that drive this glial reaction are complex and have both beneficial and deleterious effects on motor neurons. Therapeutic interventions targeting these cells are being explored. An improved understanding of the biological processes that cause neuroinflammation will help to define its medical importance and to identify the therapeutic potential of interfering with this reaction.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21349440     DOI: 10.1016/S1474-4422(11)70015-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  248 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 2.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

3.  Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes.

Authors:  Hao Pan; Handong Wang; Lin Zhu; Lei Mao; Liang Qiao; Xingfen Su
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

4.  Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis.

Authors:  Danilo B Medinas; Pablo Rozas; Francisca Martínez Traub; Ute Woehlbier; Robert H Brown; Daryl A Bosco; Claudio Hetz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

5.  Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity.

Authors:  Daisuke Umebayashi; Atsushi Natsume; Hideyuki Takeuchi; Masahito Hara; Yusuke Nishimura; Ryuichi Fukuyama; Naoyuki Sumiyoshi; Toshihiko Wakabayashi
Journal:  J Neurotrauma       Date:  2014-09-23       Impact factor: 5.269

6.  Diazoxide pretreatment prevents Aβ1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression.

Authors:  Qingxi Fu; Naiyong Gao; Jixu Yu; Guozhao Ma; Yifeng Du; Fumin Wang; Quanping Su; Fengyuan Che
Journal:  Neurochem Res       Date:  2014-04-27       Impact factor: 3.996

Review 7.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

8.  Dietary fiber and amyotrophic lateral sclerosis: results from 5 large cohort studies.

Authors:  Elinor Fondell; Eilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Laurence N Kolonel; Yikyung Park; Marjorie L McCullough; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2014-05-09       Impact factor: 4.897

9.  Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Authors:  Weihua Zhao; David R Beers; Kristopher G Hooten; Douglas H Sieglaff; Aijun Zhang; Shanker Kalyana-Sundaram; Christopher M Traini; Wendy S Halsey; Ashley M Hughes; Ganesh M Sathe; George P Livi; Guo-Huang Fan; Stanley H Appel
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

Review 10.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.